Research programme: RS7-based monoclonal antibodies - Immunomedics
Alternative Names: 1R-(E1)-(E1) antibody; 22-Rap; E1-L-thP1; E1-Rap; hRS7-Ranpirnase; hRS7-Rap; hRS7-Rap immunotoxin; Humanised monoclonal antibody RS7; Humanised RS7; IMMU 112; IMMU 112 I-131; Monoclonal antibody RS7Latest Information Update: 27 Oct 2020
At a glance
- Originator IBC Pharmaceuticals; Immunomedics
- Developer Immunomedics
- Class Camptothecins; Monoclonal antibodies; Ribonucleases
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Solid tumours